Anti-KERA/ CNA2/ KTN functional antibody

Anti-KERA/ CNA2/ KTN functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KERA/KERA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1046-Ab-1/ GM-Tg-hg-SE1046-Ab-2Anti-Human KERA monoclonal antibodyHuman
GM-Tg-rg-SE1046-Ab-1/ GM-Tg-rg-SE1046-Ab-2Anti-Rat KERA monoclonal antibodyRat
GM-Tg-mg-SE1046-Ab-1/ GM-Tg-mg-SE1046-Ab-2Anti-Mouse KERA monoclonal antibodyMouse
GM-Tg-cynog-SE1046-Ab-1/ GM-Tg-cynog-SE1046-Ab-2Anti-Cynomolgus/ Rhesus macaque KERA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1046-Ab-1/ GM-Tg-felg-SE1046-Ab-2Anti-Feline KERA monoclonal antibodyFeline
GM-Tg-cang-SE1046-Ab-1/ GM-Tg-cang-SE1046-Ab-2Anti-Canine KERA monoclonal antibodyCanine
GM-Tg-bovg-SE1046-Ab-1/ GM-Tg-bovg-SE1046-Ab-2Anti-Bovine KERA monoclonal antibodyBovine
GM-Tg-equg-SE1046-Ab-1/ GM-Tg-equg-SE1046-Ab-2Anti-Equine KERA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1046-Ab-1/ GM-Tg-hg-SE1046-Ab-2; GM-Tg-rg-SE1046-Ab-1/ GM-Tg-rg-SE1046-Ab-2;
GM-Tg-mg-SE1046-Ab-1/ GM-Tg-mg-SE1046-Ab-2; GM-Tg-cynog-SE1046-Ab-1/ GM-Tg-cynog-SE1046-Ab-2;
GM-Tg-felg-SE1046-Ab-1/ GM-Tg-felg-SE1046-Ab-2; GM-Tg-cang-SE1046-Ab-1/ GM-Tg-cang-SE1046-Ab-2;
GM-Tg-bovg-SE1046-Ab-1/ GM-Tg-bovg-SE1046-Ab-2; GM-Tg-equg-SE1046-Ab-1/ GM-Tg-equg-SE1046-Ab-2
Products NameAnti-KERA monoclonal antibody
Formatmab
Target NameKERA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KERA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1046-Ag-1Recombinant multi-species KERA/ CNA2/ KTN protein
    ORF Viral VectorvGMLP004071human KERA Lentivirus particle
    ORF Viral VectorpGMLP004071human KERA Lentivirus plasmid


    Target information

    Target IDGM-SE1046
    Target NameKERA
    Gene ID11081,16545,314771,709743,482598,101100739,280785,100063705
    Gene Symbol and SynonymsCNA2,KERA,KTN,SLRR2B
    Uniprot AccessionO60938,O62702
    Uniprot Entry NameKERA_HUMAN,KERA_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000139330
    Target ClassificationN/A

    The target: KERA, gene name: KERA, also named as CNA2, KTN, SLRR2B. The protein encoded by this gene is a keratan sulfate proteoglycan that is involved in corneal transparency. Defects in this gene are a cause of autosomal recessive cornea plana 2 (CNA2).[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.